A prospective randomized comparison of prophylactic ALG and OKT3 in cadaver kidney allograft recipients.
Hanto
D W
DW
Department of Surgery, Washington University School of Medicine, St Louis, MO 63110.
Jendrisak
M D
MD
McCullough
C S
CS
So
S K
SK
Marsh
J W
JW
Rush
T
T
Michalski
S
S
Phelan
D
D
Mohanakumar
T
T
D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D000961:Antilymphocyte Serum / Q000627:therapeutic use*; D002102:Cadaver; D003141:Communicable Diseases / Q000150:complications; D006084:Graft Rejection; D006085:Graft Survival; D006801:Humans; D007165:Immunosuppression Therapy / Q000379:methods*; D016030:Kidney Transplantation / Q000379:methods*; D016853:Muromonab-CD3; D011446:Prospective Studies; D016019:Survival Analysis
D000911:Antibodies, Monoclonal; D000961:Antilymphocyte Serum; D016853:Muromonab-CD3